Citation

Kiersch TA. Bull. Am. Acad. Psychiatry Law 1990; 18(2): 179-187.

Copyright

(Copyright © 1990, American Academy of Psychiatry and the Law)

DOI

unavailable

PMID

2142608

Abstract

Medroxyprogesterone acetate (MPA) is capable of reducing male testosterone blood levels with a corresponding reduction in sexual interest and activity. An attempt to evaluate its effectiveness with court committed sexual offenders was made with eight subjects each serving as his own control by alternating Depo-Provera injections for 16 weeks with saline injections for a corresponding 16 weeks. This paper reports the results of this study and the conclusions that appear to be appropriate.

Language: en